A Study of Cephalexin Capsules in Healthy Participants

Phase 1 Completed 28 enrolled Eli Lilly and Company Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V. · collab

RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare two different preparations of an antibiotic called cephalexin in capsules to determine if they are essentially the same. The study has two periods. Participants will receive one preparation of cephalexin in each period. At least 7 hours will pass between the study periods. The study is expected to last about 2 days for each participant, not including screening or follow-up.

Timeline

Start: 2014-04
Primary completion: 2014-05
Completion: 2014-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CEPHALEXIN ANHYDROUS	Small molecule	250 mg	Oral

Indications

No indication recorded.